The first major genetic polymorphism study of PCSK9 variants and their association with diabetes has suggested that diabetes risk is 15–20% higher in the context of a 1 mmol/l genetically predicted reduction in LDL-cholesterol [44]. This evidence concerns the gene PCSK9 and diabetes mellitus.